Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

PAUL D. YASGER;ABBOTT LABORATORIES

ABBOTT PARK, IL US

1. 20110045525 Method for Flagging a Sample - hematology analyzer is provided 02-24-2011
2. 20110040102 PROCESS FOR THE PREPARATION OF INDAZOLYL UREAS THAT INHIBIT VANILLOID SUBTYPE 1 (VR1) RECEPTORS 02-17-2011
3. 20110015216 Solid Pharmaceutical Dosage Form - providing improved oral bioavailability is disclosed for inhibitors of HIV protease 01-20-2011
4. 20110015173 PYRROLOPYRIDINE INHIBITORS OF KINASES - compounds of formula or pharmaceutical acceptable salts, STR00001 wherein R 01-20-2011
5. 20110015172 PYRROLOPYRAZINE INHIBITORS OF KINASES - compounds of formula or pharmaceutical acceptable salts, STR00001 wherein R 01-20-2011
6. 20110008430 Solid Pharmaceutical Dosage Form - providing improved oral bioavailability is disclosed for inhibitors of HIV protease 01-13-2011
7. 20110003827 HIV protease inhibiting compounds - compound of the formula STR00001 is disclosed as an HIV protease inhibitor 01-06-2011
8. 20100331353 3,9-DIAZASPIRO[5,5]UNDECANE AMIDES AND UREAS AND METHODS OF USE THEREOF 12-30-2010
9. 20100331294 4-SUBSTITUTED-2-AMINO-PYRIMIDINE DERIVATIVES 12-30-2010
10. 20100328662 METHOD AND APPARATUS FOR RAPIDLY COUNTING AND IDENTIFYING BIOLOGICAL PARTICLES IN A FLOW STREAM 12-30-2010
11. 20100324722 SYSTEM FOR MANAGING INVENTORIES OF REAGENTS 12-23-2010
12. 20100324027 DIAZAHOMOADAMANTANE DERIVATIVES AND METHODS OF USE THEREOF 12-23-2010
13. 20100323020 STABLE NANOPARTICULATE DRUG SUSPENSION - liquid pharmaceutical composition comprises an aqueous medium having suspended therein a solid particulate 12-23-2010
14. 20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same 12-23-2010
15. 20100322822 SYSTEM FOR MANAGING INVENTORY OF BULK LIQUIDS 12-23-2010
16. 20100317680 PYRIMIDINE INHIBITORS OF KINASES - compounds of formula or pharmaceutical acceptable salts, STR00001 wherein A 12-16-2010
17. 20100317568 Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus are described 12-16-2010
18. 20100311767 Method for the treatment of amyloidoses - method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof 12-09-2010
19. 20100311751 SOLID DISPERSIONS CONTAINING AN APOPTOSIS-PROMOTING AGENT 12-09-2010
20. 20100311079 ASSAY FOR CARDIAC TROPONIN AUTOANTIBODIES 12-09-2010
21. 20100310648 PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR 12-09-2010
22. 20100310607 PHARMACEUTICAL FORMULATIONS - oral formulations comprising an active agent comprising at least one of 2-[4-phenoxy]-2-methyl-propanoic acid 12-09-2010
23. 20100308066 CONTAINER - for holding granular or powdered material and formed by a top wall a bottom wall a front wall 12-09-2010
24. 20100308044 STRENGTH CONTAINER - sealable container for flowable material formed with top and flexible and stiffened bottom walls joined by front , rear , and 12-09-2010
25. 20100305126 Pyrimidine Inhibitors of Kinase Activity 12-02-2010
26. 20100305118 PYRIMIDINE INHIBITORS OF KINASE ACTIVITY 12-02-2010
27. 20100305112 PYRIMIDINE INHIBITORS OF KINASE ACTIVITY 12-02-2010
28. 20100305109 POTASSIUM CHANNEL MODULATORS - Disclosed herein are KCNQ potassium channels modulators of formula STR00001 wherein ring G 12-02-2010
29. 20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives 12-02-2010
30. 20100305086 Pharmaceutical Compositions for the Treatment of Pain 12-02-2010
31. 20100301245 Assembly For Mounting Of Tube Pinch Type Solenoid Valve 12-02-2010
32. 20100298292 MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF 11-25-2010
33. 20100298291 FUSED BICYCLIC-SUBSTITUTED AMINES AS HISTAMINE-3 RECEPTOR LIGANDS 11-25-2010
34. 20100297778 Conjugate Having Cleavable Linking Agent 11-25-2010
35. 20100291709 HUMAN NT-PRO B-TYPE NATRIURETIC PEPTIDE ASSAY HAVING REDUCED CROSS-REACTIVITY WITH OTHER PEPTIDE FORMS 11-18-2010
36. 20100286109 AMIDE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS AND METHODS OF USE THEREOF 11-11-2010
37. 20100286032 PRODRUGS OF HIV PROTEASE INHIBITORS - compound of the formula STR00001 is disclosed as a prodrug of an HIV protease inhibitor 11-11-2010
38. 20100280248 NOVEL COMPOUNDS THAT ARE USEFUL FOR IMPROVING PHARMACOKINETICS 11-04-2010
39. 20100280055 Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions 11-04-2010
40. 20100279432 INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME 11-04-2010
41. 20100278839 ANTIBODIES AGAINST NERVE GROWTH FACTOR (NGF) WITH ENHANCED IN VIVO STABILITY 11-04-2010
42. 20100273778 TREATMENT OF OSTEOARTHRITIS PAIN - This invention discloses a method of treatment of osteoarthritis pain by administration of a histamine H 10-28-2010
43. 20100273767 MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF 10-28-2010
44. 20100273168 METHOD FOR DISCRIMINATING RED BLOOD CELLS FROM WHITE BLOOD CELLS BY USING FORWARD SCATTERING FROM A LASER IN AN AUTOMATED HEMATOLOGY ANALYZER 10-28-2010
45. 20100267738 NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF 10-21-2010
46. 20100267634 Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus are described 10-21-2010
47. 20100267055 ONE-STEP IMMUNOASSAYS EXHIBITING INCREASED SENSITIVITY AND SPECIFICITY 10-21-2010
48. 20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING 10-21-2010
49. 20100261731 Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate 10-14-2010
50. 20100256139 Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus or other viruses are disclosed 10-07-2010
51. 20100251392 METHODS FOR ASSESSING THE DELIVERY OF EXOGENOUS AGENTS 09-30-2010
52. 20100249181 HIV Protease Inhibiting Compounds - compound of the formula STR00001 is disclosed as an HIV protease inhibitor 09-30-2010
53. 20100249129 COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 09-30-2010
54. 20100249105 INDOLE AND INDOLINE DERIVATIVES AND METHODS OF USE THEREOF 09-30-2010
55. 20100249087 COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 09-30-2010
56. 20100249086 Compounds As Cannabinoid Receptor Ligands 09-30-2010
57. 20100247576 NUCLEOTIDE AND AMINO ACID SEQUENCES ENCODING AN EXPORTED PROTEIN 1 DERIVED FROM PLASMODIUM VIVAX AND USES THEREOF 09-30-2010
58. 20100234456 APOPTOSIS PROMOTERS - Compounds which inhibit the activity of anti-apoptotic Mcl-1 protein compositions containing the compounds and methods of treating 09-16-2010
59. 20100234425 2-SUBSTITUTED-1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE PARP INHIBITORS 09-16-2010
60. 20100234345 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 09-16-2010
61. 20100234239 METHODS AND COMPOSITIONS FOR IDENTIFYING, CLASSIFYING AND MONITORING SUBJECT HAVING BCL-2 FAMILY INHIBITOR-RESISTANT TUMORS AND CANCERS 09-16-2010
62. 20100233175 ANTIBODIES RELATING TO PIVKAII AND USES THEREOF 09-16-2010
63. 20100227775 IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL 09-09-2010
64. 20100227387 Structure and method for handling magnetic particles in biological assays 09-09-2010
65. 20100222358 OCTAHYDRO-PYRROLO[3,4-B]PYRROLE DERIVATIVES 09-02-2010
66. 20100222316 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME 09-02-2010
67. 20100216760 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 08-26-2010
68. 20100216748 Pyrrole Derivatives and Their Methods of Use 08-26-2010
69. 20100216720 ANTIBODIES TO TROPONIN I AND METHODS OF USE THEREOF 08-26-2010
70. 20100199984 BREATH ACTUATED NASAL PUMP - breath actuated nasal drug delivery device includes a housing having a spray port 08-12-2010
71. 20100197693 NOVEL BENZENESULFONAMIDES AS CALCIUM CHANNEL BLOCKERS 08-05-2010
72. 20100196907 MARKERS TO PREDICT AND MONITOR RESPONSE TO AURORA KINASE B INHIBITOR THERAPY 08-05-2010
73. 20100196425 OROS PUSH-STICK FOR CONTROLLED DELIVERY OF ACTIVE AGENTS 08-05-2010
74. 20100190959 VANCOMYCIN B HYDROCHLORIDE CRYSTALLINE FORM 1 07-29-2010
75. 20100190822 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) 07-29-2010
76. 20100190776 Thiazoline and Oxazoline Derivatives and Their Methods of Use 07-29-2010
77. 20100184766 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 07-22-2010
78. 20100184750 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 07-22-2010
79. 20100183743 BENZTHIAZOLE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE 07-22-2010
80. 20100179318 PROCESS TO MAKE LESTAURTINIB - also known as )-2 3 07-15-2010
81. 20100178660 METHODS AND KITS FOR DETECTING HEMOGLOBIN IN TEST SAMPLES 07-15-2010
82. 20100173828 A (X - 38 .. 43) oligomers, and processes, compositions, and uses thereof 07-08-2010
83. 20100172989 ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION 07-08-2010
84. 20100170508 NASAL DRUG DELIVERY DEVICE AND METHOD - nasal drug delivery device includes a pump that supplies drug containing fluid to a spray port 07-08-2010
85. 20100168384 ANTI-VIRAL COMPOUNDS - Compounds capable of inhibiting replication of the hepatitis C virus are described 07-01-2010
86. 20100168138 Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus are described 07-01-2010
87. 20100166702 ALKYLATED INTERLEUKIN-18 AND RELATED COMPOSITIONS, KITS, AND METHODS OF MAKING AND USING SAME 07-01-2010
88. 20100160355 Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus are described 06-24-2010
89. 20100160322 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 06-24-2010
90. 20100152183 BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES 06-17-2010
91. 20100152179 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS 06-17-2010
92. 20100151578 CLINICAL TESTER WASH AND METHOD - clinical tester has been described that includes a probe to aspirate a fluid 06-17-2010
93. 20100151490 Antigenic Protein Conjugates and Process for Preparing Same 06-17-2010
94. 20100145897 GENOMIC CLASSIFICATION OF MALIGNANT MELANOMA BASED ON PATTERNS OF GENE COPY NUMBER ALTERATIONS 06-10-2010
95. 20100145894 GENOMIC CLASSIFICATION OF COLORECTAL CANCER BASED ON PATTERNS OF GENE COPY NUMBER ALTERATIONS 06-10-2010
96. 20100145893 GENOMIC CLASSIFICATION OF NON-SMALL CELL LUNG CARCINOMA BASED ON PATTERNS OF GENE COPY NUMBER ALTERATIONS 06-10-2010
97. 20100144804 Polymorph of a Pharmaceutical - new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed 06-10-2010
98. 20100144795 TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER 06-10-2010
99. 20100144783 KINASE INHIBITORS WITH IMPROVED CYP SAFETY PROFILE 06-10-2010
100. 20100144554 METHODS FOR ASSEMBLING PANELS OF CANCER CELL LINES FOR USE IN TESTING THE EFFICACY OF ONE OR MORE PHARMACEUTICAL COMPOSITIONS 06-10-2010
101. 20100137360 TRPV1 ANTAGONISTS - Disclosed herein are compounds of formula or pharmaceutically acceptable salts solvates prodrugs 06-03-2010
102. 20100136711 IMMUNOASSAY METHOD FOR PRO-GASTRIN-RELEASING PEPTIDE 06-03-2010
103. 20100136520 DETECTING HEPATITIS B VIRUS - This invention is related to methods for detecting hepatitis B virus by determining the level of hepatitis B virus surface 06-03-2010
104. 20100135861 ASSEMBLY FOR CARRYING AND HOLDING SLIDES 06-03-2010
105. 20100130558 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS 05-27-2010
106. 20100129262 AUTOMATIC LOADING OF SAMPLE TUBES FOR CLINICAL ANALYZER 05-27-2010
107. 20100124754 Cloning, Expression And Purification Of Recombinant Porcine Intrinsic Factor For Use In Diagnostic Assay 05-20-2010
108. 20100123551 SYSTEM FOR TRACKING VESSELS IN AUTOMATED LABORATORY ANALYZERS BY RADIO FREQUENCY IDENTIFICATION 05-20-2010
109. 20100120846 TRPV1 ANTAGONISTS - Disclosed herein are compounds of formula or pharmaceutically acceptable salts solvates 05-13-2010
110. 20100120753 Anti-Infective Agents - HCV polymerase inhibiting compounds having the formula : STR00001 where R 05-13-2010
111. 20100116662 NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) PROTEIN ISOFORMS ENRICHED FROM URINE AND RECOMBINANT CHINESE HAMSTER OVARY (CHO) CELLS AND RELATED COMPOSITIONS, ANTIBODIES, AND METHODS OF ENRICHMENT, ANALYSIS AND USE 05-13-2010
112. 20100115635 Methods for Assessing the Delivery of Exogenous Agents 05-06-2010
113. 20100111765 REAGENT AND SAMPLE HANDLING DEVICE FOR AUTOMATIC TESTING SYSTEM 05-06-2010
114. 20100108670 CONTAINER - for holding granular or powdered material and formed by a top wall a bottom wall a front wall 05-06-2010
115. 20100105150 ISOLATED HUMAN AUTOANTIBODIES TO NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AND METHODS AND KITS FOR THE DETECTION OF HUMAN AUTOANTIBODIES TO NGAL 04-29-2010
116. 20100104629 CATIONIC LIPIDS AND USES THEREOF - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 04-29-2010
117. 20100099738 POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF 04-22-2010
118. 20100093814 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF 04-15-2010
119. 20100093778 SUSTAINED RELEASE PARENTERAL FORMULATIONS OF BUPRENORPHINE 04-15-2010
120. 20100093730 NOVEL COMPOUNDS AS CALCIUM CHANNEL BLOCKERS 04-15-2010
121. 20100087471 INDOLE AND INDOLINE DERIVATIVES AND METHODS OF USE THEREOF 04-08-2010
122. 20100087436 METHOD OF PREVENTING OR TREATING ORGAN, HEMATOPOIETIC STEM CELL OR BONE MARROW TRANSPLANT REJECTION 04-08-2010
123. 20100081715 Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt or Derivative Thereof 04-01-2010
124. 20100078384 APPARATUS AND METHOD FOR SEPARATION OF PARTICLES SUSPENDED IN A LIQUID FROM THE LIQUID IN WHICH THEY ARE SUSPENDED 04-01-2010
125. 20100076055 Cationic Lipids and Uses Thereof - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 03-25-2010
126. 20100076051 ISOINDOLINONE KINASE INHIBITORS - Compounds having the formula STR00001 are useful for inhibiting protein tyrosine kinases 03-25-2010
127. 20100069371 THIENOPYRIDINE AND FUROPYRIDINE KINASE INHIBITORS 03-18-2010
128. 20100069349 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 03-18-2010
129. 20100069348 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 03-18-2010
130. 20100063135 POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF 03-11-2010
131. 20100063022 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 03-11-2010
132. 20100056766 PURIFICATION OF BIOLOGICAL CONJUGATES BY SIZE EXCLUSION CHROMATOGRAPHY 03-04-2010
133. 20100056762 SPECIFIC BINDING PROTEINS AND USES THEREOF 03-04-2010
134. 20100056489 TREATMENT OF NEUROPATHIC PAIN - method for treating a patient suffering from neuropathic pain comprising administering to a patient in need of such 03-04-2010
135. 20100055169 CATIONIC LIPIDS AND USES THEREOF - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 03-04-2010
136. 20100055168 CATIONIC LIPIDS AND USES THEREOF - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 03-04-2010
137. 20100048534 CRYSTALLINE LESTAURTINIB HYDRATES AND CRYSTALLINE LESTAURTINIB HEMIHYDRATE HEMIACETONITRILEATE AND CRYSTALLINE LESTAURTINIB HEMIHYDRATE HEMITETRAHYDROFURANATE 02-25-2010
138. 20100048533 LESTAURTINIB CRYSTALLINE FORM 1, CRYSTALLINE LESTAURIMIB ANHYDRATE AND AMORPHOUS LESTAURIMIB 02-25-2010
139. 20100041720 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 02-18-2010
140. 20100037921 PROBE WASHING CUPS AND METHODS - The invention provides probe washing cups and methods 02-18-2010
141. 20100035919 COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES 02-11-2010
142. 20100035879 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS 02-11-2010
143. 20100035862 NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF 02-11-2010
144. 20100029686 HCV PROTEASE INHIBITORS AND USES THEREOF 02-04-2010
145. 20100028889 COMPANION DIAGNOSTIC ASSAYS FOR CANCER THERAPY 02-04-2010
146. 20100028359 ANTIBODIES TO RECEPTOR OF ADVANCED GLYCATION END PRODUCTS (RAGE) AND USES THEREOF 02-04-2010
147. 20100024487 Surgical Instrument With Integrated Reduction And Distraction Mechanisms 02-04-2010
148. 20100022773 APOPTOSIS PROMOTERS - Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members compositions containing the compounds 01-28-2010
149. 20100022029 HOMOCYSTEINE IMMUNOASSAY - In immunoassays such as homocysteine immunoassays it is known that the measured values can be dispersed due to the influence 01-28-2010
150. 20100021878 METHOD FOR CLASSIFYING AND COUNTING BACTERIA IN BODY FLUIDS 01-28-2010
151. 20100021540 Tablets and Preparation Thereof - The present invention features processes of making tablets having reduced internal fractures 01-28-2010
152. 20100021393 Pharmaceutical Compositions Comprising Effervescent Agents and Fenofibrate 01-28-2010
153. 20100016611 METHODS FOR MAKING CENTRAL NERVOUS SYSTEM AGENTS THAT ARE TRPV1 ANTAGONISTS 01-21-2010
154. 20100016344 AMINO HETEROCYCLIC LINKED PYRIMIDINE DERIVATIVES 01-21-2010
155. 20100016277 DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS 01-21-2010
156. 20100015655 Methods and Kits for Detecting and Quantifying Damage Caused by a Parasite 01-21-2010
157. 20100015637 PIGF-1 ASSAY AND KITS AND COMPONENTS THEREOF 01-21-2010
158. 20100010055 ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USE THEREOF 01-14-2010
159. 20100010030 EXTENDED RELEASE HYDROCODONE ACETAMINOPHEN AND RELATED METHODS AND USES THEREOF 01-14-2010
160. 20100007501 CONTAINERS HAVING RADIO FREQUENCY IDENTIFICATION TAGS AND METHOD OF APPLYING RADIO FREQUENCY IDENTIFICATION TAGS TO CONTAINERS 01-14-2010
161. 20100004306 PIGF-1 Assay and kits and components thereof 01-07-2010
162. 20100004256 HETEROARYL-FUSED MACROCYCLIC PYRIMIDINE DERIVATIVES 01-07-2010
163. 20090326222 BENZOTHIAZOLE CYCLOBUTYL AMINE DERIVATIVES 12-31-2009
164. 20090325198 Non-Denaturing Lysis Reagent For Use With Capture-In-Solution Immunoassay 12-31-2009
165. 20090325197 ASSAY FOR IMMUNOSUPPRESSANT DRUGS - The invention provides immunoassays for immunosuppressant drugs wherein the assay is carried out under high salt 12-31-2009
166. 20090325193 Diagnostic Test For The Detection Of A Molecule Or Drug In Whole Blood 12-31-2009
167. 20090318689 Processes To Make Apoptosis Promoters - Processes to make compounds, including N-acylsulfonamide apoptosis promoters are disclosed 12-24-2009
168. 20090317355 ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION 12-24-2009
169. 20090314802 Apparatus And Method For Handling Fluids For Analysis 12-24-2009
170. 20090309726 SYSTEM FOR TRACKING THE LOCATION OF COMPONENTS, ASSEMBLIES, AND SUB-ASSEMBLIES IN A MEDICAL INSTRUMENT 12-17-2009
171. 20090306096 Novel Isoxazoles and Methods of Use Thereof 12-10-2009
172. 20090305348 DIAGNOSTIC TEST FOR VITAMIN B12 - isolated nucleotide sequence or fragment thereof encoding the porcine intrinsic factor wherein the porcine intrinsic 12-10-2009
173. 20090298858 POTENT PARP INHIBITORS - 1H-benzimidazole-4-carboxamides of formula STR00001 their preparation 12-03-2009
174. 20090298090 METHODS TO MEASURE IMMUNOSUPPRESSIVE TACROLIMUS, SIROLIMUS, AND CYCLOSPORIN A COMPLEXES IN A BLOOD SAMPLE 12-03-2009
175. 20090287257 CERVICAL PLATE - having a plurality of boreholes and one or more openings for aligning or positioning the boreholes on a vertebra 11-19-2009
176. 20090286784 INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS 11-19-2009
177. 20090286329 ISOLATED HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES AND METHODS AND KITS FOR DETECTING HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES 11-19-2009
178. 20090286256 ISOLATED HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES AND METHODS AND KITS FOR DETECTING HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES 11-19-2009
179. 20090285881 CATIONIC LIPIDS AND USES THEREOF - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 11-19-2009
180. 20090282932 GAS SCRUBBER FOR AUTOMATED CLINICAL ANALYZER 11-19-2009
181. 20090281582 INSTRUMENT FOR THE REDUCTION OF A ROD INTO POSITION IN A PEDICLE SCREW 11-12-2009
182. 20090281118 Selective Ligands for the Neuronal Nicotinic Receptors and Uses Thereof 11-12-2009
183. 20090280474 METHOD FOR DETECTING A VIRUS - This invention is related a method for increasing the sensitivity of detecting a viral target in a sample 11-12-2009
184. 20090275062 METHOD OF TACROLIMUS EXTRACTION AND QUANTIFICATION USING AQUEOUS DETERGENTS 11-05-2009
185. 20090273121 CLOSURE FOR CONTAINER FOR HOLDING BIOLOGICAL SAMPLES 11-05-2009
186. 20090270424 Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluor- omethyl)phenyl)urea hydrochloride 10-29-2009
187. 20090270408 AMIDE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS AND METHODS OF USE THEREOF 10-29-2009
188. 20090270364 SUBSTITUTED PYRIMIDINE DERIVATIVES - The present application describes substituted pyrimidine compounds of formula STR00001 wherein X, A 10-29-2009
189. 20090269777 IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL 10-29-2009
190. 20090264480 TRPA1 ANTAGONISTS - Compounds of formula STR00001 wherein R 10-22-2009
191. 20090264437 4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor 10-22-2009
192. 20090263894 ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF 10-22-2009
193. 20090263845 METHOD AND KIT FOR ASSESSING THE SUITABILITY OF ERYTHROCYTES FOR TRANSFUSION 10-22-2009
194. 20090263477 SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF 10-22-2009
195. 20090263407 Cationic Lipids and Uses Thereof - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 10-22-2009
196. 20090258907 COMPOUNDS USEFUL AS INHIBITORS OF ROCK KINASES 10-15-2009
197. 20090253723 PROTEIN KINASE INHIBITORS - Compounds that inhibit protein kinases compositions containing the compounds and methods of treating diseases using the 10-08-2009
198. 20090253678 MACROCYCLIC PYRIMIDINE DERIVATIVES - Macrocyclic pyrimidine compounds compositions comprising such compounds methods for making the compounds 10-08-2009
199. 20090253670 AMIDE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS AND METHODS OF USE THEREOF 10-08-2009
200. 20090252746 ERYTHROPOIETIN RECEPTOR BINDING ANTIBODIES 10-08-2009
201. 20090252652 Apparatus And Method For Handling Fluids For Analysis 10-08-2009
202. 20090247500 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 10-01-2009
203. 20090246800 IMMUNOASSAY OF ANALYTES IN SAMPLES CONTAINING ENDOGENOUS ANTI-ANALYTE ANTIBODIES 10-01-2009
204. 20090239271 FERMENTATION BROTH EXTRACTION OF K-252A - Methods for separating K-252a from the cell mass of its parent fermentation broth are disclosed 09-24-2009
205. 20090238831 MONOCLONAL ANTIBODIES AND USES THEREOF - The subject invention relates to monoclonal antibodies that may be used for example in the prevention 09-24-2009
206. 20090238766 BIOLUMINESCENT CONSTRUCT - construct comprising an amino acid sequence attached to a luciferin substrate 09-24-2009
207. 20090238436 COMPOSITION FOR IMAGING REAGENT - composition comprising a buffer and an aminoluciferase bioluminescent imaging reagent 09-24-2009
208. 20090233953 ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USES THEREOF 09-17-2009
209. 20090232801 Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof 09-17-2009
210. 20090232797 PLASMODIUM MALARIAE AND PLASMODIUM OVALE GENES AND USES THEREOF 09-17-2009
211. 20090221648 COMPOSITIONS FOR TREATMENT OF COGNITIVE DISORDERS 09-03-2009
212. 20090220510 Specific binding proteins and uses thereof 09-03-2009
213. 20090214515 METHODS OF PREPARATION OF RECOMBINANT FORMS OF HUMAN BETA-AMYLOID PROTEIN AND USES OF THESE PROTEINS 08-27-2009
214. 20090203842 Macromolecular Conjugates And Processes For Preparing The Same 08-13-2009
215. 20090203748 NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR 08-13-2009
216. 20090203709 Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor 08-13-2009
217. 20090203690 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS 08-13-2009
218. 20090203671 METHOD OF TREATING CANCER - Methods of treating cancer in patients comprising administering thereto aurora kinase inhibitors and TRAIL -related 08-13-2009
219. 20090203664 (1S,5S)-3-(5,6-DICHLORO-3-PYRIDINYL)-3,6- DIAZABICYCLO[3.2.0]HEPTANE 08-13-2009
220. 20090203038 Negative Mimic Antibody For Use as a Blocking Reagent In BNP Immunoassays 08-13-2009
221. 20090203037 Anti-T. Cruzi Antibodies and Methods of Use 08-13-2009
222. 20090198067 (1S,5S)-3-(5,6-Dichloropyridin-3-YL)-3,6-Diazabicyclo[3.2.0]Heptane Benzenesulfonate 08-06-2009
223. 20090197860 BIARYL SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES 08-06-2009
224. 20090192198 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME 07-30-2009
225. 20090192186 BIARYL SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES 07-30-2009
226. 20090192141 METHODS OF USE OF INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME 07-30-2009
227. 20090191190 Anti-ABeta Globulomer Antibodies, Antigen-Binding Moieties Thereof, Corresponding Hybridomas, Nucleic Acids, Vectors, Host Cells, Methods of Producing Said Antibodies, Compositions Comprising Said Antibodies, Uses Of Said Antibodies And Methods Of Using Said Antibodies 07-30-2009
228. 20090186912 ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: compounds and salts thereof that inter alia inhibit HCV 07-23-2009
229. 20090186877 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS 07-23-2009
230. 20090176883 TRPA1 Antagonists - Compounds of formula STR00001 wherein R 07-09-2009
231. 20090176785 METHOD OF TREATING ARTHRITIS - Methods of preventing or treating arthritis is disclosed 07-09-2009
232. 20090176784 ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: compounds and salts thereof that inter alia inhibit HCV 07-09-2009
233. 20090176783 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME 07-09-2009
234. 20090176274 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF 07-09-2009
235. 20090175847 HUMANIZED ANTIBODIES TO AB (20-42) GLOBULOMER AND USES THEREOF 07-09-2009
236. 20090163470 THIAZOLYLIDINE UREA AND AMIDE DERIVATIVES AND METHODS OF USE THEREOF 06-25-2009
237. 20090163464 BENZOTHIAZOLE AND BENZOOXAZOLE DERIVATIVES AND METHODS OF USE 06-25-2009
238. 20090162876 MYELOPEROXIDASE ASSAYS - methods and kits for determining autoantibodies to myeloperoxidase or a myeloperoxidase fragment and myeloperoxidase or a 06-25-2009
239. 20090160654 ARTICLES CONTAINING CHIPLESS RADIO FREQUENCY IDENTIFICATION ELEMENTS 06-25-2009
240. 20090158863 AUTOMATIC LOADING OF SAMPLE TUBES FOR CLINICAL ANALYZER 06-25-2009
241. 20090149501 NOVEL INDOLES ARE CANNABINOID RECEPTOR LIGANDS 06-11-2009
242. 20090149461 METHOD OF TREATING CANCER - Methods of treating cancer using N--5 5-dimethyl-1-cyclohex-1-en-1-yl)methyl)pip- erazin-1-yl)benzoyl)-4--3--1-methyl- 06-11-2009
243. 20090148871 Interdependent Assays for Detecting Two or More Analytes of Interest in A Test Sample 06-11-2009
244. 20090148866 Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase 06-11-2009
245. 20090142765 METHOD AND APPARATUS FOR RAPIDLY COUNTING AND IDENTIFYING BIOLOGICAL PARTICLES IN A FLOW STREAM 06-04-2009
246. 20090137585 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS - N-Benzoyl arylsulfonamides having the formula STR00001 are BCL-Xl inhibitors and are useful for promoting 05-28-2009
247. 20090131434 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme 05-21-2009
248. 20090131425 INHIBITORS OF PROTEIN KINASES - Compounds that inhibit Aurora-kinases compositions containing the compounds and methods of treating diseases using the 05-21-2009
249. 20090131379 VITAMIN D RECEPTOR ACTIVATORS AND METHODS OF MAKING 05-21-2009
250. 20090129990 RACK FOR SAMPLE CONTAINERS FOR CLINICAL ANALYZER 05-21-2009
251. 20090124816 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea Crystalline Form 2 ways to make it formulations comprising it and made with it and methods of 05-14-2009
252. 20090124815 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea Crystalline Form 1 ways to make it formulations comprising it and made with it and methods of 05-14-2009
253. 20090124671 TRPV1 ANTAGONISTS - compounds of formula STR00001 wherein X, R 05-14-2009
254. 20090124666 TRPV1 ANTAGONISTS - Compounds of formula STR00001 wherein R 05-14-2009
255. 20090124616 7-NONSUBSTITUTED INDOLE MCL-1 INHIBITORS 05-14-2009
256. 20090124022 ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF 05-14-2009
257. 20090123970 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF 05-14-2009
258. 20090123946 IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL 05-14-2009
259. 20090123945 CHOLINERGIC/SEROTONINERGIC RECEPTOR AND USES THEREOF 05-14-2009
260. 20090123473 HUMAN BNP IMMUNOSPECIFIC ANTIBODIES - antibodies that immunospecifically bind to human brain natriuretic peptide or a human brain natriuretic peptide 05-14-2009
261. 20090118344 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea Hydrate Crystalline Form 1 ways to make it formulations comprising it and made with it and methods 05-07-2009
262. 20090117620 AUTOMATED ANALYZER FOR CLINICAL LABORATORY 05-07-2009
263. 20090117004 SYSTEM FOR AUTOMATICALLY LOADING IMMUNOASSAY ANALYZER 05-07-2009
264. 20090111133 Gel Filtration Standard - suitable for use as molecular weight markers for gel filtration chromatography for a mobile phase with denaturant 04-30-2009
265. 20090111123 COMPOSITIONS FOR DETECTING ANTIBODIES TO BABESIA MICROTI AND METHODS OF USES THEREOF 04-30-2009
266. 20090105486 Crystalline Chemotherapeutic - N-phenyl)-N'-urea Tolueneate Crystalline Form 1, ways to make it and ways to use it are disclosed 04-23-2009
267. 20090105326 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea1/4 Ethanolate Crystalline Form 1 ways to make it formulations comprising it and made with it and 04-23-2009
268. 20090105306 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 04-23-2009
269. 20090105304 COMBINATION THERAPY FOR REDUCING SIDE EFFECTS USING CANNABINOID RECEPTOR LIGANDS 04-23-2009
270. 20090105267 OCTAHYDRO-PYRROLO[3,4-B]PYRROLE N-OXIDES 04-23-2009
271. 20090104712 HEPATITIS B PRE-S2 NUCLEIC ACID - This invention relates to a nucleic acid molecule encoding a middle Hepatitis B virus surface protein 04-23-2009
272. 20090104634 ONE-STEP IMMUNOASSAYS EXHIBITING INCREASED SENSITIVITY AND SPECIFICITY 04-23-2009
273. 20090099246 2-{(R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 2 04-16-2009
274. 20090099245 2-{(R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 1 04-16-2009
275. 20090098531 DETECTING HEPATITIS B VIRUS - This invention is related to methods for detecting hepatitis B virus by determining the level of hepatitis B virus surface 04-16-2009
276. 20090082325 Cefidinir Oral Suspension - novel powder for oral suspension of cefdinir 03-26-2009
277. 20090069275 LOW FLUSH NIACIN FORMULATION - extended-release matrix formulation capable of being directly compressed into tablets comprising niacin 03-12-2009
278. 20090068635 INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME 03-12-2009
279. 20090062345 AMIDE DERIVATIVES AS TRPV1 ANTAGONISTS - compounds of formula or pharmaceutically acceptable salts prodrugs 03-05-2009
280. 20090054499 Intermediate Release Nicotinic Acid Compositions For Treating Hyperlipidemia Which Exhibit an In Vivo Stair-Stepped Absorption Curve 02-26-2009
281. 20090054430 Inhibitors of Protein Kinases - Compounds that inhibit Aurora-kinases compositions containing the compounds and methods of treating diseases using the 02-26-2009
282. 20090054426 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS 02-26-2009
283. 20090054420 BICYCLIC-SUBSTITUTED AMINES AS HISTAMINE-3 RECEPTOR LIGANDS 02-26-2009
284. 20090054402 7-SUBSTITUTED INDOLE MCL-1 INHIBITORS - Compounds which inhibit the activity of anti-apoptotic Mcl-1 protein compositions containing the compounds 02-26-2009
285. 20090053305 Pharmaceutical Formulations - Improved pharmaceutical compositions are provided comprising one or more solubilized HIV protease inhibiting compounds 02-26-2009
286. 20090048298 Novel acetyl-CoA Carboxylase (ACC) Inhibitors and their use in Diabetes, Obesity and Metabolic Syndrome 02-19-2009
287. 20090047679 METHOD AND SYSTEM FOR ANALYZING REACTIONS USING AN INFORMATION SYSTEM 02-19-2009
288. 20090042888 Prostaglandin endoperoxide H synthase biosynthesis inhibitors 02-12-2009
289. 20090035307 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES 02-05-2009
290. 20090030196 PIM KINASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS 01-29-2009
291. 20090030016 BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS 01-29-2009
292. 20090029966 COMBINATION THERAPY WITH PARP INHIBITORS 01-29-2009
293. 20090023789 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 01-22-2009
294. 20090023743 INHIBITORS OF PROTEIN KINASES - Compounds that inhibit Aurora-kinases compositions containing the compounds and methods of treating diseases using the 01-22-2009
295. 20090022798 FORMULATIONS OF NONOPIOID AND CONFINED OPIOID ANALGESICS 01-22-2009
296. 20090020662 CONTAINER SEGMENT ASSEMBLY - suitable for use with a carousel of an analytical instrument including a container rack having the shape of a rectangular 01-22-2009
297. 20090018662 INTERVERTEBRAL IMPLANT FOR THE LUMBOSACRAL JOINT 01-15-2009
298. 20090018114 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 01-15-2009
299. 20090017560 CARDIOVASCULAR AUTOIMMUNE DISEASE PANEL AND METHODS OF USING SAME 01-15-2009
300. 20090005815 DYNAMIC STABILIZATION SYSTEM - Embodiments of the disclosure provide a device and system for dynamic spinal stabilization 01-01-2009
301. 20090005814 STABILIZATION SYSTEM AND METHOD - The disclosure relates generally to embodiments of systems and methods of spinal stabilization 01-01-2009
302. 20090005813 APPARATUS AND METHODS FOR SPINAL IMPLANTS 01-01-2009
303. 20090005787 DEVICE AND SYSTEM FOR IMPLANTING POLYAXIAL BONE FASTENERS 01-01-2009
304. 20080319432 SURGICAL ILLUMINATION SYSTEM AND METHOD - The disclosure describes embodiments of systems and methods for surgical illumination, particularly for spinal 12-25-2008
305. 20080312698 DEVICE AND SYSTEM FOR STABILIZING MOVEMENT BETWEEN BONY TISSUE AND METHOD FOR IMPLANTING 12-18-2008
306. 20080312694 DYNAMIC STABILIZATION ROD FOR SPINAL IMPLANTS AND METHODS FOR MANUFACTURING THE SAME 12-18-2008
307. 20080312458 Reactivity of Hydroxymethylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors Containing Conjugated Dienes with Phenolic Antioxidants in the Solid-State 12-18-2008
308. 20080312282 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme 12-18-2008
309. 20080312214 Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme 12-18-2008
310. 20080311676 IMMUNOASSAYS EXHIBITING REDUCED CROSS-REACTIVITY WITH HYDROPHOBIC DRUG ANALYTE METABOLITES 12-18-2008
311. 20080308600 DEVICE AND SYSTEM FOR APPLYING ROTARY IMPACT 12-18-2008
312. 20080305512 ASSAY FOR CARDIAC TROPONIN AUTOANTIBODIES 12-11-2008
313. 20080300789 Method for determining the order of execution of assays of a sample in a laboratory automation system 12-04-2008
314. 20080300634 SPINAL INTERBODY SYSTEM AND METHOD - Embodiments of the present invention provide spinal implant systems and methods 12-04-2008
315. 20080299583 METHOD AND SYSTEM FOR ANALYZING REACTIONS USING AN INFORMATION SYSTEM 12-04-2008
316. 20080299567 PRIMER AND PROBE SEQUENCES FOR DETECTING CHLAMYDIA TRACHOMATIS 12-04-2008
317. 20080294260 SPINAL IMPLANT SYSTEM AND METHOD - Embodiments of the present invention provide a spinal implant system and method 11-27-2008
318. 20080293795 COMBINATION THERAPY WITH PARP INHIBITORS 11-27-2008
319. 20080293713 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme 11-27-2008
320. 20080288002 Spinal Stabilization Systems and Methods 11-20-2008
321. 20080287676 FUSED COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR 11-20-2008
322. 20080287510 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 11-20-2008
323. 20080287419 APOPTOSIS PROMOTERS - Compounds which inhibit the activity of anti-apoptotic family protein members compositions containing the compounds and methods of 11-20-2008
324. 20080286818 BLOOD SAMPLE HANDLING METHODS FOR IMPROVED ASSAYS FOR MYELOPEROXIDASE 11-20-2008
325. 20080281362 DEVICE AND SYSTEM FOR CRANIAL SUPPORT - device and system for supporting the cranium, and a method for manufacturing 11-13-2008
326. 20080280867 COMBINATION THERAPY WITH PARP INHIBITORS 11-13-2008
327. 20080280377 HUMAN B-TYPE NATRIURETIC PEPTIDE ASSAY HAVING REDUCED CROSS-REACTIVITY WITH OTHER PEPTIDE FORMS 11-13-2008
328. 20080279859 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF 11-13-2008
329. 20080275048 Substituted Diazabicycloalkane Derivates 11-06-2008
330. 20080269897 IMPLANTABLE DEVICE AND METHODS FOR REPAIRING ARTICULATING JOINTS FOR USING THE SAME 10-30-2008
331. 20080269236 Novel 1,2,4 Oxadiazole Compounds and Methods of Use Thereof 10-30-2008
332. 20080269234 INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE 10-30-2008
333. 20080268056 INJECTABLE COPOLYMER HYDROGEL USEFUL FOR REPAIRING VERTEBRAL COMPRESSION FRACTURES 10-30-2008
334. 20080264894 CONTAINER CLOSURE ASSEMBLY - assembly comprising a container and a closure 10-30-2008
335. 20080262023 Aminomethyl Azaadamantane Derivatives and Methods of Use Thereof 10-23-2008
336. 20080255203 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE 10-16-2008
337. 20080255180 4-Substituted Azaadamantane Derivatives and Methods of Use Thereof 10-16-2008
338. 20080255179 Acetamide and Carboxamide Derivatives of Azaadamantane and Methods of Use Thereof 10-16-2008
339. 20080255178 Azaadamantane Ester and Carbamate Derivatives and Methods of Use Thereof 10-16-2008
340. 20080255123 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 10-16-2008
341. 20080249622 INTERBODY IMPLANT - includes first and second members that are configured to allow the members to be inserted into a disc space separately and then 10-09-2008
342. 20080248579 Method of stabilizing human natriuretic peptides 10-09-2008
343. 20080248493 ACRIDINIUM PHENYL ESTERS USEFUL IN THE ANALYSIS OF BIOLOGICAL SAMPLES 10-09-2008
344. 20080248491 BIOMARKER FRAGMENTS FOR THE DETECTION OF HUMAN BNP 10-09-2008
345. 20080242654 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 10-02-2008
346. 20080242653 Cyclopropyl amine derivatives - Compounds of formula wherein R 10-02-2008
347. 20080234311 IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF AMYLOID-beta PEPTIDES 09-25-2008
348. 20080234308 Amino-Aza-Adamantane Derivatives and Methods of Use 09-25-2008
349. 20080227805 SUSTAINED RELEASE PARENTERAL FORMULATIONS OF BUPRENORPHINE 09-18-2008
350. 20080220448 ANTIGENIC PROTEIN CONJUGATES AND PROCESS FOR PREPARING SAME 09-11-2008
351. 20080214528 ANTI-INFECTIVE AGENTS - HCV polymerase inhibiting compounds having the formula : where R 09-04-2008
352. 20080214524 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR 09-04-2008
353. 20080213797 IMMUNOASSAYS EXHIBITING A REDUCTION IN PROZONE PHENOMENA 09-04-2008
354. 20080210231 METERED DOSE INHALER CLEANING METHOD AND APPARATUS 09-04-2008
355. 20080206339 VERY-PURE SUPERPOROUS HYDROGELS HAVING OUTSTANDING SWELLING PROPERTIES 08-28-2008
356. 20080203193 NOZZLE-BASED ATOMIZATION SYSTEM - improved atomization system for aerosolizing liquids including a vortexing nozzle and a flat or protruding face on the 08-28-2008
357. 20080199873 Companion diagnostic assays for cancer therapy 08-21-2008